![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessSmall RNA sequencing reveals snoRNAs and piRNA-019825 as novel players in diabetic kidney disease
Micro- and macrovascular complications are common among persons with type 2 diabetes. Recently there has been growing interest to investigate the potential of circulating small non-coding RNAs (sncRNAs) as con...
-
Article
Low mitochondrial DNA content associates with familial longevity: the Leiden Longevity Study
Long-lived individuals delay aging and age-related diseases like diabetes, hypertension, and cardiovascular disease. The exact underlying mechanisms are largely unknown, but enhanced mitochondrial biogenesis a...
-
Article
The Role of Pharmacogenetics in Drug Disposition and Response of Oral Glucose-Lowering Drugs
The primary goal of type 2 diabetes mellitus (T2DM) disease management is improvement of quality of life and prevention of complications. One way to achieve these goals is improving glycemic control by using d...
-
Article
Effects of induced hyperinsulinaemia with and without hyperglycaemia on measures of cardiac vagal control
We examined the effects of serum insulin levels on vagal control over the heart and tested the hypothesis that higher fasting insulin levels are associated with lower vagal control. We also examined whether ex...
-
Article
Open AccessExome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes
Human complex metabolic traits are in part regulated by genetic determinants. Here we applied exome sequencing to identify novel associations of coding polymorphisms at minor allele frequencies (MAFs) >1% with...
-
Article
PS2 - 12. Effects of T2D and fasting glucose/insulin associated loci on insulin secretion stimulated by glucose, GLP-1 or arginine as measured by hyperglycaemic clamps
Currently more than 60 genetic loci associated with type 2 diabetes, fasting glucose and/or fasting insulin have been identified by Genome Wide Association Studies (GWAS).
-
Article
Open AccessA gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts
In this study we aimed to replicate the previously reported association between the glycaemic response to metformin and the SNP rs11212617 at a locus that includes the ataxia telangiectasia mutated (ATM) gene in ...
-
Article
PS6 - 30. Fasting and postprandial GLP-1 and GIP in relation to alanine aminotransterase and lipid metabolism in the general population
Hypertriglyceridaemia and increased amounts of liver fat are acknowledged cardiovascular risk factors, especially among type 2 diabetes patients. The incretins glucagonlike peptide 1 (GLP-1) and glucose-depend...
-
Article
Open AccessThe heritability of beta cell function parameters in a mixed meal test design
We estimated the heritability of individual differences in beta cell function after a mixed meal test designed to assess a wide range of classical and model-derived beta cell function parameters.
-
Article
Open AccessGenetic association analysis of LARS2 with type 2 diabetes
LARS2 has been previously identified as a potential type 2 diabetes susceptibility gene through the low-frequency H324Q (rs71645922) variant (minor allele frequency [MAF] 3.0%). Howeve...
-
Article
Genetic influences on the insulin response of the beta cell to different secretagogues
The aim of the present study was to estimate the heritability of the beta cell insulin response to glucose and to glucose combined with glucagon-like peptide-1 (GLP-1) or with GLP-1 plus arginine.
-
Article
Open AccessCombined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk
Variation in fasting plasma glucose (FPG) within the normal range is a known risk factor for the development of type 2 diabetes. Several reports have shown that genetic variation in the genes for glucokinase (GCK
-
Article
Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms
-
Article
Neuropeptide Y polymorphism significantly magnifies diabetes and cardiovascular disease risk in obesity: the Hoorn Study
The leucine7 to proline7 (Leu7Pro) polymorphism in preproneuropeptide Y (preproNPY) has been associated with accelerated atherosclerosis and type II diabetes, both of which are obesity-related diseases. The cu...
-
Article
Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps
Genome-wide association studies have recently identified novel type 2 diabetes susceptibility gene regions. We assessed the effects of six of these regions on insulin secretion as determined by a hyperglycaemi...
-
Article
Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms
-
Article
Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms
Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes and reduced insulin secretion. The transcription factor TCF7L2 is an essential factor for glucagon-like peptide...
-
Article
Lack of association between gene variants in the ALMS1 gene and Type 2 diabetes mellitus
-
Article
Reduced second phase insulin secretion in carriers of a sulphonylurea receptor gene variant associating with Type II diabetes mellitus
Aims/hypothesis. The sulphonylurea receptor is a subunit of the ATP-sensitive potassium channel in the pancreatic beta cell. Mutations at nt –3 of the splice acceptor site of exon 16 and a silent...
-
Article
35th Annual Meeting of the European Association for the Study of Diabetes